Why should pharma invest in digital products for those living with rare diseases?
pharmaphorum
NOVEMBER 23, 2022
New digital products always rely on early adopters to create a community and improve the product. It is this passion and fundamental need for change that suggests digital products can have a higher success rate when supporting rare disease communities. Create a human experience of care. A work of passion. About Thomas Michalak.
111 
Let's personalize your content